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Morphological effects of Pasteurella multocida Type-D dermonecrotoxin
on rat osteosarcoma cells in a nude mouse model
Abstract
Of 15 athymic nude mice that received subcutaneous implants of a rat osteosarcoma cell line, two groups of
four subsequently received either a short (group 1) or a more prolonged (group 2) course of subcutaneous
injections of the dermonecrotic toxin (DNT) of Pasteurella multocida type D. The remaining seven mice
(controls) received no DNT. Both groups of DNT-treated mice lost body weight as compared with controls.
Tumour weight, expressed as a percentage of body weight, increased in the four group 1 mice, Tumours in this
group 1 were consistently larger than those in appropriate controls, indicating that this percentage was not
simply a function of decreased body weight. The immunohistochemical labelling of proliferating cell nuclear
antigen (PCNA) and morphometric analysis of intratumoral necrosis suggested that the DNT had a
mitogenic effect and contributed to the neoplastic growth. The presence of foci of neoplastic osteoblasts in the
lungs of some DNT-treated mice suggested that the enhanced tumour growth led to an increased incidence of
metastasis.
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Summary 
Of 15 athymie nude mice that received subcutaneous implants of a rat 
osteosarcoma cell line, two groups of four subsequently received either a 
short (group 1) or a more prolonged (group 2) course of subcutaneous 
injections of the dermonecrotic toxin (DNT) of Pasteurella multocida type D. 
The remaining seven mice (controls) received no DNT. Both groups of DNT- 
treated mice lost body weight as compared with controls. Tumour weight, 
expressed as a percentage of'body weight, increased in the four group 1 mice. 
Tumours in this group 1 were consistently arger than those in appropriate 
controls, indicating that this percentage was not simply a function of decreased 
body weight. The immunohistochemical labelling of proliferating cell nuclear 
antigen (PCNA) and morphometric analysis of intratumora[ necrosis uggested 
that the DN'F had a mitogenic efikct and contributed to the neoplastic growth. 
The presence of tbci of neoplastic osteoblasts in the lungs of some DNT- 
treated mice suggested that the enhanced tumour growth led to an increased 
inc idence of  metastasis.  9 1998 W.B. Saundcrs Company Limited 
Introduction 
Strains of Pasteurd& multocida that produce dcrmonecrotoxin (DNT) are as- 
sociated with turbinate atrophy, as seen in atrophic rhinitis of swine (Dominick 
and Rimler, 1988; Martineau-Doizc et al., 1990, 1991a,b; Ghoshal and Niyo, 
1993). Experimentally, purified DNT induces marked osteoporosis when 
applied to the mucosa as an aerosol or injected subcutaneously (Dominick 
and Rimler, 1988). The mechanism by which DNT induces osteoporosis i
unclear. However, DNT may inhibit osteogenesis through a direct toxic effect 
on osteoblasts, or increase osteoclastic osteolysis (Felix et al., 1992; Foged, 
1992; Ackermann e! aL, 1993; Martineau-Doize t aL, 1993; Gwaltney et aL, 
1997). In-vitro studies have shown that DNT is cytopathogenic to several 
mesenchymal cell types, such as rat, canine or human osteosarcoma cell lines 
(Martincau-Doizc et aL, 1990, Foged, 1992; Pettit et aL, 1993a). The toxin has 
been shown to gain access to target cells by receptor-mediated binding, followed 
by endocytosis (Idali et aL, 1991; Pettit el al., 1993a). Signal transduction studies 
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indicate that DNT facilitates the coupling of a G protein to phospholipase C, 
resulting in increased intracytoplasmic calcium concentrations and phos- 
phorylation of a protein kinase C substrate via the 1,4,5 inositol tr iphosphate/ 
diacylglycerol pathway (Staddon et al., 1990, 1991, 1992; Higgins et al., 1992; 
Murphy and Rozengurt, 1992). DNT has been sequenced, and the toxA gene 
identified and cloned in an Escherichia coli vector (Peterson and Foged, 1989; 
Buys et al., 1990; Lax and Chanter,  1990; Lax et al., 1990; Peterson, 1990). 
In view of the toxin's in-vitro effect on different osteosarcoma cell lines, it was 
felt that a similar cytopathogenic effect might occur in vivo. I f  so, the toxin 
could be considered as a possible therapeutic agent for mesenchymal cell 
cancers such as osteosarcoma. The objective of the study reported here was 
to examine the effect of DNT on rat osteosarcoma (ROS) cells implanted 
subcutaneously in nude mice. 
Materials and Methods 
Toxin Preparation 
Toxin from the P multocida non-encapsulated strain P-45 was purified as previously 
described (Ackermann et al., 1992). Briefly, bacteria were grown on horse blood agar 
and lysed with ethylenediaminetetraacetic acid (EDTA), lysozyme, Triton X-100, 
phenylmethylsulphonyl fluoride, and pepstatin A. The lysate was centrifuged, and 
crude toxin was precipitated with ammonium sulphate. The precipitate was re- 
suspended in 1 ml of phenylmethylsulphonyl fluoride, centrifuged, and the supernate 
applied to a 2"6 x 19-cm DEAE-sepharose column (Pharmacia, Piscataway, NJ, USA). 
The appropriate (second) peak was concentrated and used as a purified toxin. The 
toxin contained no detectable lipopolysaccharide. 
Experimental Design 
Sixteen male athymic nude (N:NIH-bg-nu-xid) mice (Charles Rivers Laboratories, 
Wilmington, MA, USA) were housed in a germ-free isolator unit and fed sterile diet 
(Charles Rivers). After acclimatization, all mice were given 0"5 ml ROS (Majeska et 
al., 1978) (3"7 x l0  7 cells), subcutaneously, over the left flank. This number of cells 
was chosen to ensure tumour growth. By 14 days post-implantation (PI), tumour 
growth was apparent in all animals, and mice were treated as follows. Eight of the 
16 animals were used as controls, receiving no toxin, but one of these was subsequently 
excluded from the study because of a suspicion that a significant proportion of the 
tumour cells had been implanted intramuscularly, instead of subcutaneously. The 
remaining eight were divided into two treatment groups (1 and 2) of four. Mice in 
group 1 each received DNT 0" 1 gg/kg (determined as the highest sublethal dose) in 
0-1 ml diluent, subcutaneously in the dorsal cervical region, on days 16, 20, and 24 
PI. This temporal arrangement, determined in pilot studies, ensured survival of the 
mice. Four days after the final toxin treatment (i.e., on day 28 PI), four control mice, 
and the four group 1 animals were killed and their tissues harvested. The four group 
2 mice received an extended course of treatment with toxin; thus, DNT was injected 
on days 16, 20, 24, 28, 32 and 36 PI. Four days later (i.e., on day 40 PI), the remaining 
three control animals and the four group 2 mice were killed and their tissues harvested. 
Histopathology 
Entire subcutaneous tumours at the injection site were removed, weighed, measured, 
and placed in 10% neutral buffered formalin with samples of spleen, liver, and lung. 
Tissues were processed by routine methods, sections being stained with haematoxylin 
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and eosin and examined by light microscopy. Replicate sections were left unstained 
and used for immunohistochemical examination. 
Immunohislochemistry 
Sections of" neoplastic tissue and selected organs were labelled by an immuno- 
histochemical procedure to detect cells undergoing DNA synthesis, as determined by 
the presence of proliferating cell nuclear antigen (PCNA). Endogenous peroxidase 
was eliminated by incubation with hydrogen peroxide 0"5% in absolute methanol. 
Undiluted goat serum was used as blocking antibody. Primary antibody (anti-PCNA) 
(Dab, Carpenteria, CA, USA), at a 1 in 15 dilution (Tris buffered saline, pH 7"6), 
was applied at 37~ for 30 rain. Secondary antibody (goat anti-mouse, 1 in 200) was 
conjugated to streptavidin-peroxidase nd incubated with the sections for 30 rain, 
and the chromogen was a 3,3' diaminobenzidinetetrahydrochloride (DAB) substrate 
(Kirkegaard & Perry Laboratories, Gaithersburg, MD, USA)-levamisole (Vector 
Laboratories, Burlingamc, CA, USA) solution applied for 2 rain. Sections were 
counterstained with Harris's haematoxylin. Counting of cell nuclei was performed by 
light microscopy with an intraocular eticle (grid 10 x 10). By means of the reticle, 
five x 40 fields were randomly examined from each tumour section. Total numbers 
of negative nuclei per grid were counted, followed by counting of positively labelled 
nuclei. A single operator perforrned all the nuclear counts. Percentages of dividing 
nuclei in each tumour were determined from the data obtained. 
Mo~phornetric Ana!r~is 
Image analysis was carried out by the Iowa State University Image Analysis Facility 
with a Zeiss SEM-IPS image analysis system (Zeiss-Kontron; IBAS version 2.00). 
Microscope slides were placed on a copy stand and transilluminated with a ChromaPro 
45 lightbox. Images were captured by a Sony DXC-3000A 3 CCD colour video 
camera, with a 60-ram macro lens. The operator then selected the area to be measured 
by drawing around the edge of the imaged sample, excluding any extraneous tissue. 
The neoplastic tissue (dark purple staining) and necrotic tissue (light purple staining) 
were interactively discriminated from the resulting image. These areas were auto- 
matically measured and recorded in the system's database. The amount of tumour 
represented as necrotic tissue was determined by calculating the area of necrosis as 
a percentage value of necrotic tissue plus tumour tissue. 
Statistical Analysis 
Statistical results were obtained with an analysis of variance (ANOVA) based on a 
completely randomized esign. P<0-05 was considered statistically significant. 
Resu l ts  
Macroscopical Appearance ofTurnouts 
The gross appearance of  the neoplasms was consistent throughout the study. 
After implantation, all mice developed tumours, varying from 0"2 to 2'4 cm 
in diameter. The tumours were cream to pale grey in colour, the cut surface 
displaying occasional oci of haemorrhage or necrosis, or both. They  were 
muhilobulated, focal to multifocal in distribution, and located subcutaneously. 
Very occasionally, tumours showed patchy infiltration of  adjacent issues, and 
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Table 1 
Effects o f  DNT t reatment  on mice  given ROS 
Mouse group Mouse Mouse Turnout Tumour Necro~i~' Number oJ 
no. weight welght ~e,'-eight as as % of divz~ling cefl~'/ 








1 27,73 0.61 2.20 15,01 1Z50 
2 25.37 0.52 2.00 8.50 17,00 
3 25.46 0.31 1.20 1.39 14100 
4 24.85 1.74 7,00 33,07 20.00 
1 22.4(/ 1.70 7.50 50.42 25.50 
2 23.97 1.42 5,90 29,73 15.00 
3 22.92 2.23 9.70 25,40 23.50 
4 18.62 1.38 7.40 28,56 23.50 
1 32.30 1.21 3.80 24.36 42.50 
2 25.70 1.18 4.60 16.48 44.00 
3 28.18 N/A* N/A* 23.6 / 38.50 
1 21.63 1.71 7.90 27.39 45.00 
2 22.66 0.90 3.90 31.36 67.00 
3 21.66 0.19 0.87 19.18 55.50 
4 16.90 0.56 3.30 48,51 43.50 
* Control mouse, group 2 intramuscular dcposition of ROS precluded accurate tumour extraction and 
measurement. 
one mouse (control for group 2) showed local invasion of the spinal column 
and retroperitoneum; these findings were believed to have resulted from the 
accidental intramuscular deposition of some osteosarcoma cells. 
Microscopical Appearance ofTurnouts 
Both control and DNT-treated tumours were characterized by a non-en- 
capsulated, well-delineated focus of neoplastic mesenchymal cells, arranged 
in sheets and haphazard aggregates on a dense fibrous stroma. Neoplastic 
cells, which were pyriform to cuboidal in shape, with modest amounts of 
eosinophilic cytoplasm, contained oval to irregular nuclei with dispersed 
chromatin and one to three distinct nuclei. Intricately branching trabeculae 
of osteoid were often present between neoplastic osteoblasts. Mitotic figures 
were common (one to three per x 40 field). Randomly distributed foci of 
necrosis and multifocal areas of mineralization were also present. These loci, 
which were entirely intratumoral, were characterized by prominent zones of 
coagulative necrosis with central areas of mineralization. The margin of each 
necrotic zone was distinct from the adjacent, viable neoplastic tissue. 
Bo@ Weight 
The toxin-treated mice (groups 1 and 2) had lower body weights than the 
controls at the time of killing (P=0"0269, group 1; P=0"0154, group 2). The 
body weights of group 2 mice were slightly but not significantly lower than 
those of group 1 (Table 1). 
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Fig. 1. rl'umour ~odule in control ROS-implanted mousc. PCNA labelling, x 40. Note intense nuclear 
IabeIIhlg o1" positive cells (closed arrow)i Negativel~ lai~clled nuclci Iack intensity (open arrow}. 
Bar, 20 lain. 
Tumour Weigh94 
Tumour weights in group 1 mice tended to be higher than those of the control 
mice for group 1, but this difference was not statistically significant (P= 
0-0564). In contrast, mice from group 2 had significantly reduced tumour 
weights (P=05059) (Tab le  1). 
Turnout Weighl /Body 14~eight (Percentage) 
Toxin-treated mice from group 1 demonstrated a statistically significant higher 
percentagc of body weight as tumour weight than did control mice for group 
1 (P=0"0255). This trend continued in group 2, but was not statistically 
significant (P= 0-9294) (Table 1). 
Necrotic 7~ssue / Turnout (Percentage) 
The amount of necrosis per tumour was consistently highcr, but not significantly 
so, in the toxin-treated animals from both groups (P=0"0754, group 1; P= 
0"2405, group 2)(Table 1). 
Number of Dividing Nuclei 
Immunohistochemical labelling of PCNA showed no significant difference in 
the numbers of mitotically active ceils between toxin-treated and control 
groups (P= 0" 1225, group 1 ; P= 0" 1535, group 2). Numbers of dividing cells 
were somewhat higher tbr toxin-treated mice, but the trend was mild. Positive 
labelling, which was restricted to nuclei, varied from intense, diffuse labelling 
of nucleoplasm, to variable amounts of stippled to marginated intranuclear 
positive reactivity (Fig. 1). Nucleoli were also positive. The pattern of labelling 
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Fig 2. Tumour nodule in DNT-treated ROS-implanted mouse. PCNA labelling, x 20. Note distinct line 
of demarcation (arrowheads) between ecrotic (N) and viable (V) tissue. Bar, 40 gm. 
was multifocal and randomly distributed throughout all the tumours, and 
displayed marked variability. However, there was consistent and intense 
labelling of nuclei in cells immediately adjacent o areas of necrosis (Fig. 2). 
This feature was found in nearly all tumours examined, giving prominent 
collars of positively labelled neoplastic ells around zones of coagulative 
necrosis. 
Metastasis 
Four out of fifteen (26"6%) mice demonstrated metastasis to the lung. No 
metastases were observed in the liver or spleen. The metastatic foci varied 
from randomly-placed microclusters of five to 10 neoplastic osteoblasts to 
aggregates which occupied larger portions of pulmonary parenchyma. None 
of the metastatic loci were visible grossly. Three (group 1, one; group 2, two) 
out of our of these mice had been treated with toxin. Examination of additional 
sections of lung from all mice failed to reveal the presence of additional 
metastases. 
Discuss ion  
The DNT of P. multocida type D causes weight loss and lesions in a number 
of organs in several animal species (Cheville and Rimler, 1989; Thurston et 
al., 1989; Williams et al., 1990; Ackermann et al., 1992; Foged, 1992). Pettit 
et al. (1993b) showed that in rats the observed weight loss could be blocked 
by treatment with toxoid. Toxin-treated, tumour-implanted mice (groups 1 
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and 2) in the present study showed statistically significant weight loss. The 
toxin may produce this eft~ct either directly by inducing anorexia nd decreased 
energ T intake, or indirectly through the eft~cts of inflammatory cytokines uch 
as interleukin-1 or -6 (IL-1 or IL-6) or tumour necrosis factor (TNF). In 
addition, the possibility of decreased weight gain as a result of chemical 
mediators directly secreted by neoplastic ells, or the combined effects of such 
mediators and inflammatory cytokines, leading to cachexia, cannot be ruled 
out. The possible efi~ct of DNT on weight gain in this model must be 
considered, in light of the fact that sublethal doses of toxin were administered, 
to assess the protein's possible therapeutic activity. However, DNT appeared 
to contribute to weight loss. 
Tumour weights from the toxin-treated mice of group 1 were consistently, 
but not significantly, higher than those of the appropriate control mice. 
Conversely, group 2 toxin-treatcd mice demonstrated ecreased tumour 
weights. It is possible that the effect of DNT was influenced by the age of the 
turnouts, but the group 1 results require confirmation with a larger number 
of animals. The suggestion that treatment with toxin increases tumour size is 
consistent with earlier reports that DNT is mitogenic to some cell lines irz vitro, 
particularly Swiss 3T3 fibroblasts (Rozengurt el a[., 1990; Staddon el al., 1990, 
1991). Cellular responses to DNT vary widely and some cell lines are resistant 
to the toxin's effect (Sterner-Kock et al., 1995). The significantly increased 
amount of body weight attributable to turnout mass in the toxin-treated mice 
of group 1 suggests that the efi~ct of the toxin in such mice is at least two- 
fold. DNT may simultaneously contribute to the significant weight loss, and 
enhance the mitogenic potential of neoplastic osteoblasts. This observation is
supported by the fact that control mice had smaller tumours, and increased 
body weights. Theretbre, there is a suggestion that in group 1 mice the toxin 
enhanced the prolit~rative potential of the tumours. 
The amount of necrosis observed in each tumour was consistently higher 
in toxin-treated mice (groups 1 and 2). The mechanism of necrosis production 
is unclear, but the following possibilitics exist: DNT is directly toxic to the 
ncoplastic ells; DNT causes necrosis by inducing a second population of cells 
to produce humoral factors that kill neoplastic cells; the toxin stimulates 
neoplastic proliferation at a rate which exceeds the vascular supply, and 
necrosis due to ischaemia results. It is tempting to speculate that the extent 
of necrosis is related to the action of the toxin, but there is no direct evidence 
that such is the case. Indeed, the tumour necrosis might result from (1) 
outstripping of the blood supply by neoplastic growth, (2) infiltration of 
the tumour by inflammatory cells (although in the present study minimal 
inflammation was associated with tumours), or (3) the local release ofcytokines. 
The type of necrosis ranged from coagulative to caseous, and was generally 
limited to the centre of tumour nodules. Proliferation of tumour cells, in 
contrast, generally occurred at the periphery of tumour nodules. 
Proliferation indices were determined by PCNA, a 36-kDa nuclear protein, 
which increases in concentration during the G1 phase of the cell cycle, peaks 
during the S phase, and begins to decline in G2 (Trere, 1993). PCNA labelling 
varied within individual tumours, and between groups. However, as a trend 
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(which proved not to be statistically significant), toxin-treated mice in both 
groups 1 and 2 consistently showed increased numbers of positively labelled 
nuclei. This finding is consistent with the increased tumour weights noted in 
group 1, and the increased tumour weights as a percentage of body weight 
seen in groups 1 and 2. These three parameters, taken in concert, suggest 
that the toxin, rather than causing turnout growth to decrease, stimulated 
neoplastic proliferation. Previous studies have indicated that DNT binds a 
cell surface receptor and activates a G protein and phospholipase C; this, in 
turn, initiates the production of 1,4,5 inositol triphosphate, and diacylglycerol 
(Staddon et al., 1990, 1991, 1992; Higgins et al., 1992; Murphy and Rozengurt, 
1992). 1,4,5 Inositol triphosphate mediates the release of calcium from the 
endoplasmic reticulum, and increased intracytoplasmic calcium induces everal 
cellular activities, one of which is, in conjunction with diacylglycerol, the 
activation of protein kinase C (Darnell et al., 1990). Tumour promoters (e.g., 
phorbol esters) use protein kinase C as a target, which may play an important 
role in cell proliferation (Darnell et al., 1990). It is reported that increased 
cytoplasmic alcium concentrations may result in loss of gap-junction per- 
meability, thereby inhibiting intercellular communication; this is also proposed 
as a mechanism in carcinogenesis (Klaunig and Ruch, 1990). Such metabolic 
pathways would implicate DNT in the stimulation of cell growth, in particular, 
neoplastic growth. A distinct pattern of cell proliferation was noted in as- 
sociation with necrotic zones. A prominent rim of cells adjacent to non-viable 
tissue reacted intensely for PCNA. The change was consistent in both groups, 
and did not vary with toxin treatment. In turnouts in which necrosis was 
substantial, these proliferative areas often coalesced into larger zones of 
positively labelled cells. Since areas of necrosis were observed internally in all 
tumours, the area of most significant proliferation would appear to be just 
external to dying cells. Therefore, new tumour growth occurred from within, 
and the neoplasms could be thought of as expanding masses with the foci of 
most significant proliferation just adjacent o the areas of necrosis. 
Evidence of metastasis was seen in four of 15 mice; three of these four were 
toxin-treated, two belonging to group 2. All metastases were in the lung. The 
metastatic loci, none of which were grossly visible, varied microscopically 
from microemboli to prominent aggregates that obliterated large areas of 
parenchyma. The relationship of metastasis to toxin treatment is unclear, but 
increased cell proliferation and tumour growth might lead to the selection of 
a metastatic phenotype. If toxin treatment stimulates uch mitogenic activity 
in osteosarcoma cells, an increased incidence of metastasis might occur as a 
sequel. An increased sample size would be useful in establishing whether this 
is a significant possibility. Locally invasive tumour growth was observed in 
one mouse, but this was felt to be due to intramuscular rather than subcutaneous 
deposition of ROS. Pulmonary metastasis did not occur in this animal. 
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